Published in Immunotherapy Weekly, January 16th, 2008
"After expansion in vitro, the functional IFN-gamma producing M3271 specific CD8(+) T cells were detected in 30.8% (8/26) of HLA-A2(+) MAGE-A3(+) HCC patients. The effector CD8+ T cells could release cytotoxic molecules of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.